InsidersTradesSigma
Follow the 메지온 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 메지온 has published 1 insider filings. Market capitalisation: €1,984.6bn. The latest transaction was reported on 18 March 2026 (Purchase). Among the most active insiders: 노성일. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
메지온是一家在XKRX市场上市的医疗保健和制药公司。它专注于开发各种疾病的创新疗法。